EMCDDA continues support for EU drug-related regional programme in Central Asia

The Central Asian Drug Action Programme (CADAP), is currently in its sixth phase  and reflects the EU’s long-term engagement with Central Asian partners to help further strengthen their national policies in drug demand reduction. 22.02.2018